OrbiMed's mutual fund business was launched in 1989 to invest in health sciences companies on a worldwide basis. As one of the largest and oldest asset management firms dedicated to the healthcare sector, OrbiMed has the scale, resources and experience necessary to seek out promising investment opportunities. We manage several mutual funds for individual investors:

Eaton Vance Worldwide Health Sciences Fund.

A publicly-offered open-end mutual fund which seeks superior healthcare investment opportunities on a worldwide basis.

More detailed information about this fund, including a fund prospectus, is available on the Eaton Vance website or by calling (800) 262-1122 from the United States.

Worldwide Healthcare Trust PLC

This Trust seeks superior healthcare investment opportunities on a worldwide basis. The Trust was launched in 1995, and is a closed-end UK Investment Trust which trades on the London Stock Exchange.

More detailed information about this Trust is available on the Frostrow Capital website or by calling +44 (0) 203 0084910.

Biotechnology Growth Trust PLC

This Trust seeks superior investment opportunities primarily from development-stage biotechnology companies. The Trust is a closed-end UK Investment Trust which trades on the London Stock Exchange.

More detailed information about this Trust is available on the Frostrow Capital website or by calling +44 (0) 203 0084910.

Skandia Healthcare Fund

A publicly-offered open-end mutual fund which seeks superior biotechnology and pharmaceutical investment opportunities on a worldwide basis. More detailed information about this fund, including a fund prospectus, is available on the Skandia website or by calling (800) 262-1122 from the United States.

We appreciate your interest in our firm and investment funds.

   Back to Funds